期刊
PEDIATRICS AND NEONATOLOGY
卷 62, 期 4, 页码 347-353出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.pedneo.2020.12.013
关键词
breast milk; human milk oligosaccharides; immune modulators; infant formula; infant nutrition
类别
Breastfeeding and human milk are considered the best for infant nutrition. Human milk oligosaccharides (HMOs) have various beneficial effects on infants' health and their composition is influenced by factors like lactation stage and maternal genetics. While HMOs supplemented infant formulae are well-tolerated, further clinical studies are needed to fully understand their significance in infant nutrition.
Breast feeding and human milk are the standards for infant feeding and nutrition. Human milk oligosaccharides (HMOs) are the third most abundant solid component in human milk. To date, more than 200 structural different HMOs have been identified and some can be synthesized by the food industry. HMOs are one of the major differences between human milk and formula milk, and current evidence demonstrates their various beneficial effects toward infants' health: acting as anti-adhesive antimicrobials, immune modulators, and intestinal cell response modulators, as well as providing prebiotics effect and neurodevelopment and cogni-tion effects. HMOs compositions vary among mothers, influenced by the stage of lactation, duration of pregnancy and maternal genetic factors. However, there are still some unknown factors affecting the compositions of HMOs and requiring further research for clarification. A combination of preclinical and clinical cohort studies may help to identify whether an individ-ual HMO contributes to disease protection. In recent years, 20-fucosyllactose (20-FL) and lacto-N-neotetraose (LNnT) have been approved as food ingredients by official authorities. Infant formulae supplemented with these HMOs are well-tolerated. However, more prospective clin-ical studies are warranted to elucidate HMOs' significance in infant nutrition. Breast milk feeding remains the best option for infants nutrition and development. Whenever breast milk is not adequate or unavailable, infant formula supplemented with HMOs might be considered as an alternative. Copyright (C) 2021, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据